Aveanna Healthcare Holdings Net Income 2020-2024 | AVAH
Aveanna Healthcare Holdings net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Aveanna Healthcare Holdings Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-135 |
| 2022 | $-662 |
| 2021 | $-117 |
| 2020 | $-57 |
| 2019 | $-77 |
| Aveanna Healthcare Holdings Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-43 |
| 2024-06-30 | $14 |
| 2024-03-31 | $-11 |
| 2023-12-31 | $-26 |
| 2023-09-30 | $-102 |
| 2023-06-30 | $26 |
| 2023-03-31 | $-32 |
| 2022-12-31 | $-238 |
| 2022-09-30 | $24 |
| 2022-06-30 | $-474 |
| 2022-03-31 | $25 |
| 2021-12-31 | $-126 |
| 2021-09-30 | $2 |
| 2021-06-30 | $1 |
| 2021-03-31 | $6 |
| 2020-12-31 | $-10 |
| 2020-09-30 | $-7 |
| 2020-06-30 | $-78 |
| 2020-03-31 | $38 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.873B | $1.895B |
| Aveanna Healthcare Holdings Inc. is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna Healthcare Holdings Inc. is based in Atlanta, Georgia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.704B | 11.92 |
| Quest Diagnostics (DGX) | United States | $16.912B | 17.14 |
| DaVita (DVA) | United States | $12.098B | 15.65 |
| Encompass Health (EHC) | United States | $9.453B | 22.29 |
| Chemed (CHE) | United States | $7.853B | 24.14 |
| Elanco Animal Health (ELAN) | United States | $5.843B | 13.91 |
| RadNet (RDNT) | United States | $5.284B | 117.02 |
| Option Care Health (OPCH) | United States | $3.848B | 18.23 |
| Amedisys (AMED) | United States | $2.744B | 19.53 |
| LifeStance Health (LFST) | United States | $2.698B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.350B | 27.57 |
| Astrana Health (ASTH) | United States | $1.974B | 26.99 |
| U.S Physical Therapy (USPH) | United States | $1.380B | 36.27 |
| Pennant (PNTG) | United States | $0.938B | 37.92 |
| Atai Life Sciences (ATAI) | Germany | $0.200B | 0.00 |
| Bioqual (BIOQ) | United States | $0.059B | 0.00 |
| Daxor (DXR) | United States | $0.039B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |